<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Medical Diagnostics Articles in XPRT</title><link>https://www.xprt.com/medical-diagnostics/articles</link><description>Medical Diagnostics Articles in XPRT</description><image><url>https://www.xprt.com/images/logo.gif</url><link>https://www.xprt.com/medical-diagnostics/articles</link><title>Medical Diagnostics Articles in XPRT</title></image><item><title>Find B&amp;C’s Updates and Analysis of Chemical Regulatory Impacts of COVID-19 in one Place</title><link>https://www.xprt.com/news/find-b-c-s-updates-and-analysis-of-chemical-regulatory-impacts-of-covid-19-in-one-place-987959</link><description><![CDATA[From new product or new use approvals, to impact on chemical supply chains, Bergeson &amp; Campbell, P.C. (B&amp;C&reg;) monitors key federal and international chemical legislative and regulatory initiatives to keep firm clients and friends informed. We have compiled a comprehensive and frequently updated listing of our content related to the coronavirus crisis that we hope will serve as a useful, one-click source of information: www.lawbc.com/uploads/docs/COVID-19.pdf.]]></description><pubDate>Wed, 20 May 2020 00:00:00 +0000</pubDate><guid>https://www.xprt.com/news/find-b-c-s-updates-and-analysis-of-chemical-regulatory-impacts-of-covid-19-in-one-place-987959</guid><category>chemical regulations</category><category>chemical analysis</category><category>coronavirus</category><category>COVID 19</category><category>coronavirus crisis</category></item></channel></rss>
